Trial · NCT04979052
Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia
NCT04979052, Phase 2, Completed, Radboud University Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia. Trials, record NCT04979052. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04979052
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia
- NCT number
- NCT04979052
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 65 participants, actual
- Lead sponsor
- Radboud University Medical Center
- Conditions
- Candidemia
- Interventions
- Interferon Gamma-1B
- First posted
- 2021-07-27
- Last updated
- 2026-06-22
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to first negative blood culture | Day 14 | |
| Secondary | Time to treatment success | Day 14 | microbiological eradication of Candida from the blood and any other site of infection; resolution of fever; resolution of other diagnostic variables, such as imaging results, where applicable; and no new signs of infection. The time at which all the variables are met is defined as the date of resolution of infection. |
| Secondary | Percentage of patients with mycological outcomes | through intervention completion, an average at day 11 and 2 and 4 weeks after intervention completion | |
| Secondary | Percentage of patients with treatment success | through intervention completion, an average at day 11 and 2 and 4 weeks after intervention completion | |
| Secondary | Overall survival | Study day 28 | |
| Secondary | Number of patients with Treatment Emergent Adverse Events (TEAEs). | Study day 49 | |
| Secondary | Sequential Organ Failure Assessment (SOFA) score | Study day 14 | |
| Secondary | Adverse events | Study day 14 | |
| Secondary | Body weight | Study day 49 | kg |
| Secondary | BMI | Study day 49 | kg/m\^2 |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04979052
GET https://conductscience.org/api/trials/v1/NCT04979052/registered